Concepedia

Author

Kerri Lipinski

Princeton University

Also Known As

K. LIPINSKI, K. Lipiński, Kerri K Lipinski, Kerri K. Lipinski, Kerri Lipinski

12

Publications

309

Citations

7

H-Index

34

Concepts

All Affiliations

Princeton UniversityPfizer (United States)
KL

About

Kerri Lipinski is an author at Princeton University specializing in medicine, drug discovery, and natural sciences.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

7

7

291

2

Natural Sciences

4

4

130

3

Biochemistry

3

3

93

4

Cell Biology

3

3

198

5

Chemical Biology

1

1

12

Kerri Lipinski

×

7

Publications

291

Citations

7

H-Index

YearCitations

Investigation of leucine‐rich repeat kinase 2

Vasanti S. Anand, Laurie J. Reichling, Kerri Lipinski,

FEBS Journal

2008

112

Identification and Characterization of a Leucine-Rich Repeat Kinase 2 (LRRK2) Consensus Phosphorylation Motif

Pooja Pungaliya, Yuchen Bai, Kerri Lipinski,

PLoS ONE

2010

71

Identification of pyridazino[4,5-b]indolizines as selective PDE4B inhibitors

Andrew F. Donnell, Paul Dollings, John A. Butera,

Bioorganic & Medicinal Chemistry Letters

2010

39

Discovery of a Novel, Orally Efficacious Liver X Receptor (LXR) β Agonist

Ya‐Jun Zheng, Linghang Zhuang, Kristi Fan,

Journal of Medicinal Chemistry

2016

32

Disruption of ShcA signaling halts cell proliferation — characterization of ShcC residues that influence signaling pathways using yeast

Julia Heinrich, Seung Kwak, David Howland,

Cellular Signalling

2005

15

Synthesis and structure–activity relationship of a novel series of heterocyclic sulfonamide γ-secretase inhibitors

Jun Pu, Anthony F. Kreft, Suzan H. Aschmies,

Bioorganic & Medicinal Chemistry

2009

12

Brain penetrant liver X receptor (LXR) modulators based on a 2,4,5,6-tetrahydropyrrolo[3,4-c]pyrazole core

Colin M. Tice, Paul Noto, Kristi Fan,

Bioorganic & Medicinal Chemistry Letters

2016

10

Page 1